Carrie Melvin - Feb 8, 2023 Form 4 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role
COO
Signature
/s/ Lara Meisner, Attorney-in-Fact for Carrie Melvin
Stock symbol
VRDN
Transactions as of
Feb 8, 2023
Transactions value $
$0
Form type
4
Date filed
2/10/2023, 03:51 PM
Previous filing
Jun 24, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRDN Stock Option (Right to Buy) Award $0 +54K $0.00 54K Feb 8, 2023 Common Stock 54K $34.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in equal monthly installments through February 8, 2027, subject to the Reporting Person's continued service to Issuer through each vesting date.